New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 1, 2014
10:00 EDTANET, SRPT, SGMO, RNA, BIN, PZG, PTCT, FLML, FINL, CBAY, CWST, SCMPOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Arista Networks (ANET) initiated with a Neutral at Citigroup... Casella Waste (CWST) initiated with a Hold at Stifel... CymaBay Therapeutics (CBAY) initiated with an Outperform at Cowen... Finish Line (FINL) initiated with a Buy at Jefferies... Flamel Technologies (FLML) initiated with an Outperform at Leerink... PTC Therapeutics (PTCT) initiated with an Outperform at Oppenheimer... Paramount Gold & Silver (PZG) initiated with a Buy at Noble Financial... Progressive Waste (BIN) initiated with a Hold at Stifel... Prosensa (RNA) initiated with an Outperform at Oppenheimer... Sangamo (SGMO) initiated with an Overweight at JPMorgan... Sarepta (SRPT) initiated with an Outperform at Oppenheimer... Sucampo (SCMP) initiated with a Buy at Roth Capital.
News For ANET;CWST;CBAY;FINL;FLML;PTCT;PZG;BIN;RNA;SGMO;SRPT;SCMP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
October 10, 2014
10:12 EDTRNAProsensa begins NDA submission to FDA for drisapersen
Subscribe for More Information
10:01 EDTSCMPOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:01 EDTSCMPSucampo upgraded to Buy from Hold at Maxim
Subscribe for More Information
October 9, 2014
18:47 EDTSCMPOn The Fly: After Hours Movers
UP AFTER EARNINGS: Helen of Troy (HELE), up 3%... Barracuda Networks (CUDA), up marginally after reporting second quarter results. ALSO HIGHER: Sucampo Pharmaceuticals (SCMP), up 19.2% after announcing settlement agreement resolving patent litigation on AMITIZA... Civeo (CVEO), up 15% after Greenlight Capital reported a 9.99% stake in the company... EXCO Resources (XCO), up 10.6% after T. Boone Pickens says that company approached by buyers, reported by Bloomberg... EXACT Sciences (EXAS), up 3.7% after announcing final national coverage determination for Cologuard... US Ecology (ECOL), up 2.5% following announcement that it will replace Measurement Specialties (MEAS) in S&P 600. DOWN AFTER EARNINGS: Procera Networks (PKT), down 19.3%... Sizmek (SZMK), down 13.9% following third quarter revenue guidance... VOXX International (VOXX), down 12.5%... Knowles (KN), down 8.1% after lowering third quarter guidance... Microchip (MCHP), down 8.2% after lowering second quarter guidance... Juniper Networks (JNPR), down 3.6% after lowering third quarter outlook. ALSO LOWER: GT Advanced Technologies (GTAT), down 23.3% following a Bloomberg report that it will as to wind down sapphire operations.
18:36 EDTPTCTPTC Therapeutics 3M share Spot Secondary priced at $36.25
Subscribe for More Information
16:49 EDTSCMPSucampo announces settlement agreement resolving patent litigation on AMITIZA
Subscribe for More Information
14:55 EDTSRPTHospital says deputy showing no signs of Ebola, AP reports
Subscribe for More Information
14:24 EDTSRPTCDC head compares Ebola to AIDS, Washington Post says
Subscribe for More Information
14:13 EDTSRPTFirst Ebola vaccine trial in West Africa started, NBC News reports
Subscribe for More Information
12:06 EDTSRPTLakeland Industries continues surge amid Ebola fears
Subscribe for More Information
09:41 EDTFINLBofA/Merrill retail analysts hold an analyst/industry conference call
Subscribe for More Information
October 8, 2014
16:25 EDTPTCTPTC Therapeutics files to sell 3M shares of common stock
Credit Suisse and Citigroup are acting as joint lead book-running managers for the offering. Cowen and Company, Deutsche Bank Securities and RBC Capital Markets are acting as book-running managers.
11:22 EDTSRPTChimerix falls after Ebola patient taking experimental drug dies
Shares of Chimerix (CMRX) are moving lower after the Texas Health Presbyterian Hospital Dallas announced that Thomas Eric Duncan succumbed to Ebola. Duncan was being treated with Chimerix's experimental drug Brincidofovir. Shares of Chimerix dropped 9% following the news to $30.19. Other makers of experimental Ebola treatments include Tekmira (TKMR), Sarepta (SRPT) and BioCryst (BCRX).
10:00 EDTANETOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:23 EDTFINLCitigroup to hold a tour
Athletic Footwear Mall Tour travels to Roosevelt Field Mall, Garden City, New York on October 8.
07:10 EDTANETArista Networks initiated with a Buy at MKM Partners
Target $115.
October 7, 2014
10:15 EDTFLMLFlamel Technologies management to meet with Leerink
Meeting to be held on New York on October 9 hosted by Leerink.
10:05 EDTRNAProsensa has a conference call hosted by JPMorgan
Subscribe for More Information
07:46 EDTPTCTPTC Therapeutics weakness a buying opportunity, says Oppenheimer
Oppenheimer believes that the Street is underestimating the opportunity for PTC Therapeutics' (PTCT) Translarna in the most severe patients with Cystic fibrosis. The firm thinks the drug is not competitive with, and can potentially be complemented by, therapies from Vertex (VRTX). Oppenheimer views the weakness in PTC as a buying opportunity and keeps its Outperform rating on the shares.
07:24 EDTSGMOAlliance for Regenerative Medicine
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use